“Diagnosis goes hand in hand with vaccination, and of course with therapies as well. What CRISPR is doing is providing for rapid turnaround testing at a lower cost and higher throughput than we’ve had with other technologies. We’ll see that happening in various testing labs, certainly around the U.S. And the nice thing about that is it really does go hand in hand with these vaccines that are coming forward.”
IGI Founder and President Jennifer Doudna returns to Conversations with Michael Milken to discuss the latest COVID-19 vaccine developments, how CRISPR can be used for diagnosing viral infections, and how we can accelerate scientific discoveries and innovations for better health care.
Click below to listen to or download the full 21-minute podcast or click here to listen to the previous episode featuring Jennifer.
Revolutionary, with UC Berkeley’s Jennifer Doudna
Conversations with Mike Milken | Milken Institute | January 8, 2021
Read the transcript of this podcast here.